BioSpace News Archive

ReCode Therapeutics to Present Preclinical Data Using SORT-LNP ™ and RNA Platforms to Rescue CFTR Function at the 44th European Cystic Fibrosis Conference (ECFS)

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, presented new findings at the Digestive Disease Week® (DDW) 2021 virtual meeting from a survey highlighting disease burden and care-seeking behavior among adult patients with irritable bowel syndrome with constipation (IBS-C) during the COVID-19 pandemic.

Horizon Therapeutics plc announced that the Company will participate in the following upcoming conferences

AMSURG, a division of Envision Healthcare and a national leader in outpatient care, and Icahn School of Medicine at Mount Sinai, world-renowned for its groundbreaking research, released new findings on colorectal cancer (CRC)

PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s proprietary Versamune ® T-cell activating technology, today announced that they will host a company conference call on June 8, 2021 at 8:00 am ET

US Orthopedic Alliance (USOA) has selected 2bPrecise to provide its precision medicine platform to USOA’s network of more than 100 orthopedic surgeons.

Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, announced today that the American College of Obstetricians and Gynecologists (ACOG), in its updated guidance for Management of Symptomatic Uterine Leiomyomas , supports the use of laparoscopic radiofrequency ablation (Lap-RFA) for the trea

Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health,” the “Company” or the “Offeror”) announced today that it has commenced a cash tender offer (the “Tender Offer”) to purchase any and all of its outstanding 7.00% Senior Secured Notes due 2024 (the “Notes”).

Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it has joined the FLAMIN-GO Project consortium of academic and industry leaders in rheumatology, autoimmune disease research, and drug discovery and development to create an organ-on-a-chip solution toward personalized care and improved outcomes for rheumatoid arthr

Subsidiary Health Karma publishes content to educate and support individuals seeking first time behavioral health assistance